Document:

STOCK
PURCHASE AGREEMENT

 

This
STOCK Purchase Agreement (this “Agreement”) is made and entered
into effective as of the 4th day of June 2018, by and between Immune Therapeutics, Inc., a Florida corporation (“IMUN”),
and Cytocom, Inc., a Delaware corporation (“Company”).

 

RECITALS

 

WHEREAS,
the Company wishes to sell to IMUN, and IMUN wishes to acquire from the Company, 10% of the Company’s issued and outstanding
common stock in exchange for cancellation of all debt owed IMUN from the Company, subject to the terms and conditions of this
Agreement.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the premises and
mutual covenants, agreements, understandings, undertakings, warranties and promises, and intending to be legally bound thereby,
IMUN and Company (each, a “Party,” and collectively, the “Parties”), do hereby covenant and agree as follows:

 

1.
PURCHASE AND SALE OF STOCK

 

1.1
Purchase and Sale. Upon the terms and subject to the conditions set forth in this Agreement, the Company agrees to sell and
issue to IMUN, and IMUN agrees to purchase from Company, newly-issued common shares of the Company representing 10% of
the Company’s common stock on the Closing Date, calculated on a fully diluted basis (the “Shares”).

 

1.2
Cancellation of Debt. In consideration for the Company’s issuance of Shares to IMUN, IMUN agrees to cancel all debt
owed by the Company to IMUN (the “Debt”). The parties acknowledge and agree that the total outstanding Debt is $ 4,000,000,
which Debt is represented by two promissory notes in the outstanding amounts of $1,500,000 dated September 30, 2014 and $2,500,000,
respectively (the “Notes”). The Notes and Debt shall be automatically cancelled, null and void, upon valid issuance
of the Shares to IMUN.

 

1.3
Restated License Agreement. The parties agree to, as a condition to the closing of the transaction contemplated hereby, enter
into an amended and restated license agreement (“Restated License Agreement”), substantially in the form included
herewith as Exhibit A.

 

1.4
Closing. The closing of the purchase of the Shares will take place electronically no later than June 7, 2018 (“Closing
Date”). On or before the Closing Date, the Company will deliver to IMUN a duly executed copy of this Agreement, a duly executed
copy of the Restated License Agreement and a validly issued certificate representing the Shares in IMUN’s name. On or before
the Closing Date, IMUN will deliver to the Company a duly executed copy of this Agreement and the Restated License Agreement and
all Notes for cancellation.

 

    	 	1 of 5	 
	 	 	_____ Initials; _____ Initials

 

     

    

 

2.
IMUN COVENANTS, REPRESENTATIONS AND WARRANTIES 

 

IMUN
hereby covenants, represents and warrants to Company as follows:

 

2.1
Authorization; Binding Effect. IMUN has all requisite power and authority to (i) execute and deliver this Agreement, and (ii)
to carry out and perform its obligations under the terms of this Agreement. This Agreement has been duly authorized, executed
and delivered and constitutes the legal, valid and binding obligation of IMUN, enforceable in accordance with its terms, except
as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or other laws relating
to or affecting the enforcement of creditors’ rights generally in effect from time to time and by general principles of
equity.

 

2.2
No Conflicts with Agreements, Etc.
Neither the execution and delivery of this Agreement nor the fulfillment of or compliance with the terms and provisions hereof,
will conflict with, or result in a breach or violation of any of the terms, conditions or provisions of, or constitute a default
under, any contract, agreement, mortgage, indenture, lease, instrument, order, judgment, statute, law, rule or regulation to which
the Party is subject.

 

2.3
Securities Representations. IMUN acknowledges and agrees that the Shares are characterized as “restricted securities”
under applicable U.S. federal and state securities laws, including Rule 144 promulgated under the Securities Act of 1933, and
that pursuant to these laws, IMUN must hold the Shares indefinitely unless subsequently registered with the SEC and qualified
by state authorities, or an exemption from such registration and qualification requirements is available. It is further understood
that the stock certificates to be issued pursuant to the terms of this Agreement may bear one or more legends restricting the
transfer of the Shares or as otherwise required by applicable state law. IMUN is acquiring the shares of common stock issuable
hereunder for its own account for investment only and not with a view towards the public sale or distribution thereof and not
with a view to or for sale in connection with any distribution thereof.

 

2.4
Due Diligence. IMUN has received and reviewed the Company’s governing documents including, but not limited to, its Articles
of Incorporation, By-Laws and Shareholder Agreements, and hereby agrees to be bound thereto and abide by the provisions thereof.
IMUN has been afforded the opportunity to ask questions of the Company and has received complete and satisfactory answers to any
such inquiries. If desired, IMUN has consulted its own advisors with respect to its proposed purchase of the Shares. Except as
set forth herein, no representations or warranties have been made to IMUN by the Company, or any officer, partner, agent, representative,
employee or affiliate thereof and, in entering into this transaction, the IMUN is not relying upon any information, other than
that contained herein.

 

2.5
Ownership of Debt. IMUN has not transferred or encumbered the Debt or Notes and has the full authority to cancel the Debt
pursuant to this Agreement.

 

3.
COMPANY COVENANTS, REPRESENTATIONS AND WARRANTIES 

 

The
Company hereby covenants, represents and warrants to IMUN as follows:

 

3.1
Authorization; Binding Effect. The Company has all requisite power and authority to (i) execute and deliver this Agreement,
(ii) to issue its Shares as contemplated hereunder, and (iii) to carry out and perform its obligations under the terms of this
Agreement. This Agreement has been duly authorized, executed and delivered and constitutes the legal, valid and binding obligations
of the Party, enforceable in accordance with its respective terms, except, in each case, as such enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium, or other laws relating to or affecting the enforcement of creditors’
rights generally in effect from time to time and by general principles of equity.

 

    	 	2 of 5	 
	 	 	_____ Initials; _____ Initials

 

     

    

 

3.2
No Conflicts with Agreements, Etc.
Neither the execution and delivery of this Agreement nor the fulfillment of or compliance with the terms and provisions hereof,
nor the transfer of the Shares, will conflict with, or result in a breach or violation of any of the terms, conditions or provisions
of, or constitute a default under, any contract, agreement, mortgage, indenture, lease, instrument, order, judgment, statute,
law, rule or regulation to which the Party is subject.

 

3.3
 Valid Issuance of Shares. All
Shares to be issued pursuant to this Agreement, when transferred, shall be duly and validly issued, fully paid, and nonassessable,
and will be transferred free of liens, encumbrances and restrictions on transfer other than (a) restrictions on transfer under
this Agreement and under applicable state and federal securities laws, and (b) restrictions on transfer under the Company’s
governing documents.

 

3.4
Legal Proceedings.
There is no action, suit, proceeding, arbitration, claim, investigation or inquiry pending or, to the Company’s knowledge,
threatened by or before any governmental body against the Company which, individually or in the aggregate, would reasonably be
expected to have a material adverse effect on the Company, nor are there any orders, writs, injunctions, judgments or decrees
outstanding of any court or government agency or instrumentality and binding upon the Company or its affiliates that would reasonably
be expected to have a similar material adverse effect on the Company or its operations.

 

4.
GENERAL PROVISIONS

 

4.1
Attorneys’ Fees. If any legal action or any arbitration or other proceeding is brought for the enforcement of this Agreement,
or because of an alleged dispute, breach, default, or misrepresentation in connection with any of the provisions of this Agreement,
the successful or prevailing party or parties shall be entitled to recover actual attorneys’ fees and other costs incurred
in that action or proceeding, in addition to any other relief to which it may be entitled.

 

4.2
Further Assurances. Subject to the terms and conditions of this Agreement, each of the Parties hereto will use all reasonable
efforts to take, or cause to be taken, all action, and to do, or cause to be done, all things necessary, proper or advisable under
applicable laws and regulations to consummate and make effective the transactions pursuant to this Agreement.

 

4.3
Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective
successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other
than the signatories hereto any rights, remedies, obligations, or liabilities under or by reason of this Agreement.

 

4.4
Assignment. Anything in this Agreement to the contrary notwithstanding, the Parties may not assign any of their rights or
interests in and under this Agreement without the prior written consent of the other Party, and any attempted assignment without
such consent shall be null and void and without any force or effect whatsoever.

 

4.5
Governing Law; Venue. This Agreement shall be governed by and construed under the laws of the State of Florida, disregarding
any principles of conflicts of law that would otherwise provide for the application of the substantive law of another jurisdiction.

 

4.6
Counterparts. The Parties agree that this Agreement may be executed in one or more counterparts, each of which shall be an
original, and all of which, taken together, shall constitute one and the same instrument. The Parties further agree that this
Agreement may be executed by telecopy or fax of the signature page, which countersigned faxed signature will for all purposes
be deemed an execution.

 

    	 	3 of 5	 
	 	 	_____ Initials; _____ Initials

 

     

    

 

4.7 Notices. Unless
otherwise provided, any notice required or permitted under this Agreement shall be given in writing, and shall be deemed effectively
given upon personal delivery to the Party to be notified, or four (4) days after deposit with the United States Post Office, postage
prepaid and addressed to the Party to be notified. Any notice to a Party shall be sent to its addresses set forth on the signature
pages hereof, or at such other address as a Party may designate by advanced written notice to the other Party.

 

4.8 Entire Agreement;
Amendments and Waivers. This Agreement constitutes the full and entire understanding and agreement between the Parties with
regard to the subjects hereof, and supersedes any and all prior or contemporaneous written or oral negotiations, agreements, representations,
and understandings of the Parties with respect to such subject matter. Any term of this Agreement may be amended and the observance
of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively),
only with the written consent of the Parties.

 

4.9 Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable
in accordance with its terms.

 

4.10 Interpretation. The
titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting
this Agreement. No rule of construction or interpretation that disfavors the party drafting this Agreement or any of its provisions
will apply to the interpretation of this Agreement. Instead, this Agreement will be interpreted according to the fair meaning of
its terms. Where the context or construction requires, all words applied in the plural shall be deemed to have been used in the
singular, and vice versa; the masculine shall include the feminine and neuter, and vice versa; and the present tense shall include
the past and future tense, and vice versa.

 

    	 	4 of 5	 
	 	 	_____ Initials; _____ Initials

 

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Stock Purchase Agreement as of the date first set forth above.

 

	 	“IMUN”	 	“Company”
	 	 	 	 
	 	Immune Therapeutics, Inc.	 	Cytocom, Inc.

 

	X:	 	 	X:	 
	 

        Printed:
	 	 	 

        Printed:
	 
	 

        Its:
	 	 	 

        Its:
	 
	 

        Dated:
	 	 	 

        Dated:
	 
	 

        Address:
	 	 	 

        Address:
	 
	 	 

         
	 	 	 

 

    	 	5 of 5	 
	 	 	_____ Initials; _____ Initials

 

     

    

 

EXHIBIT
A

 

Restated
License Agreement

 

(see
attached)ex_116177.htm

Exhibit 10.1

 

EXECUTION COPY

 

FACILITY AGREEMENT WAIVER AND FIFTH 

AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTE

 

This FACILITY AGREEMENT WAIVER AND FIFTH AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTE (this “Amendment”) dated as of June 11, 2018, (i) waives certain terms of the Facility Agreement (as defined below) by and between KemPharm, Inc., a Delaware corporation (the “Borrower”), and Deerfield Private Design Fund III, L.P. (the “Lender”) and (ii) amends certain terms of that certain Senior Secured Convertible Note in the original principal amount of $10,000,000 issued by the Borrower to the Lender on June 2, 2014 (as the same may have been previously or in the future be amended, modified, restated or otherwise supplemented from time to time, the “Senior Secured Convertible Note”). Capitalized terms used herein which are defined in the Facility Agreement, unless otherwise defined herein, shall have the meanings ascribed to them in the Facility Agreement.

 

RECITALS:

 

A.     The Borrower and the Lender have entered into that certain Facility Agreement, dated as of June 2, 2014 (as the same may have been previously or in the future be amended, modified, restated or otherwise supplemented from time to time, the “Facility Agreement”).

 

B.     Upon the execution and delivery of the Facility Agreement, the Lender disbursed the First Disbursement, which included (among other loans) a term loan of $10,000,000, which is evidenced by the Senior Secured Convertible Note.

 

C.     The Facility Agreement obligates the Borrower to pay to the Lender 33-1/3% of the outstanding original principal amount of the Senior Secured Convertible Note on each of the fourth (the “2018 Payment Date”) and fifth anniversaries of the Agreement Date, (the Principal (as defined in the Senior Secured Convertible Note) payment due on the fourth anniversary of the Agreement Date under the Senior Secured Convertible Note being hereinafter referred to as the “2018 Payment”).

 

D.     On the 2018 Payment Date (i) the 2018 Payment in the amount of $3,333,333.33 (the “2018 Payment Amount”) was due and (ii) accrued and unpaid interest on the entire outstanding Principal amount of the Senior Secured Convertible Note was $168,287.67 (such accrued and unpaid interest being hereinafter referred to as the “Accrued Interest Amount”).

 

E.      Pursuant to this Amendment (and subject to the terms and conditions hereof) the parties desire to provide for the conversion of the 2018 Payment and the Accrued Interest Amount into shares of the common stock, par value, $0.0001 per share (“Common Stock”), of the Borrower, and make certain other clarifications and amendments, upon the terms, and subject to the conditions, set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

 

 

 

 

ARTICLE I.     

CONVERSION OF SENIOR SECURED CONVERTIBLE NOTE; FACILITY AGREEMENT WAIVER AND AMENDMENT OF SENIOR SECURED CONVERTIBLE NOTE

 

Section 1.01.     Application of Conversions to 2018 Payment; Facility Agreement Waiver. Notwithstanding anything to the contrary contained in the Facility Agreement (including Section 2.3 thereof) or the Senior Secured Convertible Note (or in any Conversion Notices (as defined in the Senior Secured Convertible Note)), subject to the terms and conditions of the Senior Secured Convertible Note (as modified hereunder) and this Amendment, the Lender hereby converts the 2018 Payment Amount and the Accrued Interest Amount into 598,568 shares of Common Stock (the “2018 Payment Date Conversion Shares”). Pursuant to such conversion (which shall be effective without the need for a separate Conversion Notice), which shall be deemed effective and consummated on the date hereof (immediately following the execution and delivery of this Amendment by all parties hereto), the Borrower hereby agrees to issue the 2018 Payment Date Conversion Shares to the Lender, and upon such issuance, the 2018 Payment and the Accrued Interest Amount shall be deemed to have been satisfied in full. For the avoidance of doubt, (i) the amounts converted hereunder shall be applied against, and reduce, the Principal amount of the 2018 Payment together with accrued but unpaid interest on the entire outstanding Principal amount of the Senior Secured Convertible Note as of June 2, 2018 and (ii) any Principal amounts converted following the date hereof (unless otherwise agreed by the parties) shall be applied against and reduce Principal amounts in inverse order of maturity. Effective upon the Lender’s receipt of the 2018 Payment Date Conversion Shares, Lender hereby agrees that (i) the 2018 Payment Date Conversion Shares are issued in full discharge and satisfaction of the 2018 Payment Amount and the Accrued Interest Amount; and (ii) upon Lender’s receipt of the 2018 Payment Date Conversion Shares, the Borrower shall have no continuing obligation to pay to Lender the 2018 Payment Amount or the Accrued Interest Amount. Effective upon the Lender’s receipt of the 2018 Payment Date Conversion Shares hereunder, Lender hereby waives any and all demands, claims, suits, actions, causes of actions, proceedings, assessments and rights in respect of payment of the 2018 Payment Amount and the Accrued Interest Amount, including without limitation any rights arising from any past or present default or Event of Default under the Facility Agreement, the Senior Secured Convertible Note or any other Transaction Document regarding the Borrower’s failure to pay the 2018 Payment Amount and Accrued Interest Amount prior to the date hereof. The Borrower and Lender hereby agree that in the event any terms of the Transaction Documents conflict with this Section 1.01, the terms of this Section 1.01 shall control.

 

Section 1.02.     Delivery of Shares. Notwithstanding anything to the contrary contained in the Senior Secured Convertible Note, no later than two (2) Trading Days following the date hereof, the Borrower shall cause the transfer agent for the Common Stock to credit the aggregate number of 2018 Payment Date Conversion Shares to the Lender’s or its designee’s balance account with The Depository Trust Company through its Deposit/Withdrawal-At-Custodian system in accordance with the account information provided by the Lender.

 

2

 

 

Section 1.03.     Application of Conversions to Principal or Interest. For the avoidance of doubt, the holder of a Senior Secured Convertible Note may elect, in its sole discretion, at any time and from time to time, to convert all or part of the Principal and/or interest accrued under such Senior Secured Convertible Note, whether or not such interest converted is equal to the interest accrued on the Principal amount (if any) converted at such time. The form of Conversion Notice shall be deemed amended to reflect such clarification.

 

Section 1.04.     Amendments to Senior Secured Convertible Note. The Senior Secured Convertible Note is hereby amended as follows:

 

(a)     Section 1 of the Senior Secured Convertible Note is hereby amended by adding the following definition of “Standard Settlement Period”:

 

‘“Standard Settlement Period” means the standard settlement period for equity trades effected by U.S. broker-dealers, expressed in a number of Trading Days, as in effect on the date the applicable Conversion Notice (as defined below) is received or deemed received by the Company.’

 

(b)     Clause (B) of Section 2(c)(ii) is hereby amended and restated in its entirety as follows:

 

“in the case of a conversion after an IPO Event, on or before the second (2nd) Trading Day (or, if earlier, the last day of the Standard Settlement Period) following the date of receipt or deemed receipt by the Company of such Conversion Notice (the “Share Delivery Date”)”

 

(c)     Clause (2) of Section 2(c)(ii) of the Senior Secured Convertible Note is hereby amended by replacing the reference to “three (3) Business Days” with a reference to “two (2) Trading Days.”

 

(d)     Section 2(c)(v)(A) of the Senior Secured Convertible Note is hereby amended by inserting the phrase “any of” before the phrase “the Unrestricted Conditions”

 

(e)     Section 2(e) of the Senior Secured Convertible Note is hereby amended by adding the following as subparagraph (iv) thereof:

 

“(iv)     Delivery of Electronic Shares. Following an IPO Event, in lieu of delivering physical certificates representing the Common Stock issuable upon conversion or legend removal, or representing Conversion Shares, upon written request of Holder, the Company shall cause its Transfer Agent to electronically transmit the Conversion Shares issuable upon conversion of the Note to the Holder by crediting the account of Holder’s prime broker with the Depository Trust Company through its Deposit/Withdrawal at Custodian (DWAC) system. The time periods for delivery and penalties described herein shall apply to the electronic transmittals described herein. Any delivery not effected by electronic transmission shall be effected by delivery of physical certificates.”

 

3

 

 

ARTICLE II.

REPRESENTATIONS AND WARRANTIES

 

Section 2.01.     Representations and Warranties of the Lenders. The Lender hereby represents and warrants to the Borrower as of the date of this Amendment as follows:

 

(a)     Organization and Good Standing. The Lender is an entity duly otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.

 

(b)     Authority. The Lender has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Amendment and the Transaction Documents (as amended hereby), and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each of this Amendment and the consummation by it of the transactions contemplated hereby and by the Transaction Documents (as amended hereby) have been duly authorized by all necessary action on the part of the Lender and no further action is required in connection herewith or therewith.

 

(c)     Valid and Binding Amendment. This Amendment has been duly executed and delivered by the Lender and this Amendment and the Transaction Documents (as amended hereby) constitute the valid and binding obligations of the Lender, enforceable against the Lender in accordance with their terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.

 

(d)     Non-Contravention. The execution and delivery of this Amendment by the Lender and the performance by the Lender of its obligations hereunder and under the Transaction Documents (as amended hereby) does not (i) violate any provision of the Lender’s organizational documents, or (ii) conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Lender is subject, or by which any of the Lender’s Notes is bound or affected.

 

Section 2.02.     Representations and Warranties of the Borrower. The Borrower hereby represents and warrants to the Lender as of the date of this Amendment as follows:

 

(a)     Organization and Good Standing. The Borrower is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.

 

(b)     Authority. The Borrower has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Amendment and the Transaction Documents (as amended hereby) and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Amendment by the Borrower and the consummation by it of the transactions contemplated hereby and by the Transaction Documents (as amended hereby) have been duly authorized by all necessary action on the part of the Borrower, and no further action of the Borrower, its board of directors or stockholders is required in connection herewith or therewith.

 

4

 

 

(c)     Consents. The Borrower is not required to obtain any consent from, authorization or order of, or, other than as contemplated under Section 3.01 of this Amendment, make any filing or registration with any Governmental Authority or any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its respective obligations under or contemplated by this Amendment or the Transaction Documents (as amended hereby), in each case, in accordance with the terms hereof or thereof.

 

(d)     Valid and Binding Amendment. This Amendment has been duly executed and delivered by the Borrower and this Amendment and the Transaction Documents (as amended hereby) constitute the valid and binding obligations of the Borrower, enforceable against the Borrower in accordance with their terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.

 

(e)     Non-Contravention. The execution and delivery of this Amendment and the performance by the Borrower of its obligations hereunder and under the Transaction Documents (as amended hereby) does not (i) violate any provision of the Borrower’s organizational documents, (ii) conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Borrower is subject, or by which any property or asset of the Borrower is bound or affected, (iii) require any permit, authorization, consent, approval, exemption or other action by, notice to or, other than as contemplated under Section 3.01 of this Amendment, filing with, any court or other federal, state, local or other governmental authority or other Person, (iv) violate, conflict with, result in a material breach of, or constitute (with or without notice or lapse of time or both) a material default under, or an event which would give rise to any right of notice, modification, acceleration, payment, cancellation or termination under, or in any manner release any party thereto from any obligation under, any permit or contract to which the Borrower is a party or by which any of its properties or assets are bound, or (v) result in the creation or imposition of any Lien on any part of the properties or assets of the Borrower. Other than as waived under Section 1.01 of this Amendment, no Event of Default exists.

 

(f)     Conversion Price. The Conversion Price as of the date hereof is $5.85 per share of Common Stock, subject to adjustment as provided in the Senior Secured Convertible Note. There has not occurred any event or trigger described in Section 2(f)(i) of the Senior Secured Convertible Note that (i) has resulted in or otherwise required an adjustment of the Conversion Price, or (ii) otherwise obligated the Borrower to deliver a notice pursuant to Section 2(f)(vii) of the Senior Secured Convertible Note.

 

5

 

 

ARTICLE III.

COVENANTS

 

Section 3.01.     Disclosure; Confidentiality. On or before 8:00 a.m., New York time, on the first Business Day following the date of this Agreement, the Borrower shall file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by this Amendment, attaching this Amendment and disclosing any other presently material non-public information (if any) provided or made available to the Lender (or any of its agents or representatives) on or prior to the date hereof (the “8-K Filing”). From and after the filing of the 8-K Filing, the Borrower shall have disclosed all material, non-public information (if any) provided or made available to the Lender (or any of its agents or representatives) by Borrower or any of its officers, directors, employees, Affiliates or agents in connection with the transactions contemplated by this Amendment or otherwise on or prior to the date hereof. Notwithstanding anything contained in this Amendment to the contrary, and without implication that the contrary would otherwise be true, the Borrower expressly acknowledges and agrees that the Lender shall not have (unless expressly agreed to by the Lender after the date hereof in a written definitive and binding agreement executed by the Borrower and the Lender) any duty of trust or confidence with respect to, or a duty not to trade on the basis of, any information regarding the Borrower.

 

Section 3.02.     Taxes. The Borrower shall be responsible for paying all present or future stamp, court or documentary, recording, filing or similar Taxes that arise from any payment or issuance made under, from the execution, delivery, performance or enforcement of, or otherwise with respect to, this Amendment.

 

Section 3.03.     Fees and Expenses. The Borrower shall promptly reimburse the Lender for all of its reasonable and documented out-of-pocket, costs, fees and expenses, including legal fees and expenses, incurred in connection with the negotiation and drafting of this Amendment and the consummation of the transactions contemplated hereby and thereby.

 

ARTICLE IV.

MISCELLANEOUS

 

Section 4.01.     Entire Agreement. This Amendment and the Transaction Documents (as amended hereby) constitute the entire agreement, and supersede all other prior and contemporaneous agreements and understandings, both oral and written, between the Lender and the Borrower with respect to the subject matter hereof.

 

Section 4.02.     Amendments and Waivers. No provision of this Amendment may be waived or amended except in a written instrument signed by the parties hereto.

 

Section 4.03.     Successors and Assigns. All of the covenants and provisions of this Amendment by or for the benefit of the Lender or the Borrower shall bind and inure to the benefit of their respective successors and assigns. No party hereunder may assign its rights or obligations hereunder without the prior written consent of the other parties hereto.

 

6

 

 

Section 4.04.     Applicable Law. As part of the consideration and mutual promises being exchanged and given in connection with this Amendment, the parties hereto agree that all claims, controversies and disputes of any kind or nature arising under or relating in any way to the enforcement or interpretation of this Amendment or to the parties’ dealings, rights or obligations in connection herewith, including disputes relating to the negotiations for, inducements to enter into, or execution of, this Amendment, and disputes concerning the interpretation, enforceability, performance, breach, termination or validity of all or any portion of this Amendment shall be governed by the laws of the State of New York without regard to its choice or conflicts of laws principles.

 

Section 4.05.     Counterparts; Effectiveness. This Amendment may be executed and delivered in any number counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement. In the event that any signature to this Amendment is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. No party hereto shall raise the use of a facsimile machine or e-mail delivery of a “.pdf” format data file or other reproduction of this Amendment to deliver a signature to this Amendment or the fact that such signature was transmitted or communicated through the use of a facsimile machine or e-mail delivery of a “.pdf” format data file as a defense to the formation or enforceability of a contract, and each party hereto forever waives any such defense.

 

Section 4.06.     Effect of Headings. The section and subsection headings herein are for convenience only and not part of this Amendment and shall not affect the interpretation thereof.

 

Section 4.07.     Avoidance of Doubt. The parties hereto hereby agree, for the avoidance of doubt, that this Amendment constitutes a “Transaction Document” and the term “Obligations” as used in the Transaction Documents shall include all liabilities and obligations of the Borrower under this Amendment, under the Facility Agreement (as amended hereby) and under the other Transaction Documents (as amended hereby).

 

Section 4.08.     Further Assurances. The Borrower hereby agrees, from time to time, as and when requested by the Lender, to execute and deliver or cause to be executed and delivered, all such documents, instruments and agreements, including secretary’s certificates, stock powers and irrevocable transfer agent instructions, and to take or cause to be taken such further or other action, as the Lender may reasonably deem necessary or desirable in order to carry out the intent and purposes of this Amendment and the Transaction Documents (as amended hereby).

 

Section 4.09.     No Strict Construction. The language used in this Amendment will be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction will be applied against any party.

 

7

 

 

Section 4.10.     Interpretative Matters. Unless otherwise indicated or the context otherwise requires, (i) all references to Sections, Schedules, Appendices or Exhibits are to Sections, Schedules, Appendices or Exhibits contained in or attached to this Amendment, (b) words in the singular or plural include the singular and plural and pronouns stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter, (c) the words “hereof,” “herein” and words of similar effect shall reference this Amendment in its entirety, and (d) the use of the word “including” in this Amendment shall be by way of example rather than limitation.

 

Section 4.11.     Reaffirmation. The Borrower, as issuer, debtor, grantor, pledgor, mortgagor, guarantor or assignor, or in other any other similar capacity in which it grants Liens or security interests in its property hereby (i) acknowledges and agrees that it has reviewed this Amendment, (ii) ratifies and reaffirms all of its obligations, contingent or otherwise, under each of the Transaction Documents (as amended hereby) and (iii) to the extent the Borrower granted Liens on or security interests in any of its property pursuant to any such Transaction Document as security for the Obligations under or with respect to the Transaction Documents, ratifies and reaffirms such grant of security interests and Liens and confirms and agrees that such security interests and Liens hereafter secure all of the Obligations (as amended hereby). The Borrower hereby consents to this Amendment and acknowledges that this Amendment is a Transaction Document and each of the other Transaction Documents (as amended hereby) remains in full force and effect and is hereby ratified and reaffirmed. Any reference in the Transaction Documents to “hereunder,” hereof,” “herein,” or words of like import referring to such agreement shall refer to such Transaction Document as amended by this Amendment.

 

[The remainder of the page is intentionally left blank]

 

8

 

 

IN WITNESS WHEREOF, each party hereto has caused this Facility Agreement Waiver and Fifth Amendment to Senior Secured Convertible Note to be duly executed as of the date first written above.

 

	 	
			THE BORROWER:

			
	 	 	 
	 	
			KEMPHARM, INC.

			
	 	 	 
	 	By:	
			/s/ R. LaDuane Clifton

			
	 	Name:	
			R. LaDuane Clifton

			
	 	Title:	
			Chief Financial Officer, Secretary and Treasurer

			

 

 

 

 

 

 

[Signature page to Facility Agreement Waiver and Fifth Amendment to Senior Secured Convertible Note]

 

 

 

 

 

	 	
			LENDERS:

			
	 	 
	 	
			DEERFIELD PRIVATE DESIGN FUND III, L.P. 

			
	 	 
	 	By:	
			Deerfield Mgmt III, L.P., its General Partner

			
	 	By:	
			J.E. Flynn Capital III, LLC, its General Partner

			
	 	 	 
	 	By:	
			/s/ David Clark

			
	 	Name:	
			David Clark

			
	 	Title:	
			Authorized Signatory

			

 

 

 

 

 

 

[Signature page to Facility Agreement Waiver and Fifth Amendment to Senior Secured Convertible Note]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]